ADVERTISEMENT

Patients with aggressive type of breast cancer can look forward to cheaper medicines


PETALING JAYA: Good news for patients who could not afford an exorbitant medicine for an aggressive type of breast cancer.

The Health Ministry has approved the biosimilar version of trastuzumab (a monoclonal antibody), a targeted therapy, for women with HER2-positive breast cancer patients, said Dr Dzulkefly Ahmad.

breast cancer

   

ADVERTISEMENT